{
    "Trade/Device Name(s)": [
        "D3 Ultra DFA Respiratory Virus Screening & ID Kit",
        "Respiratory Virus DFA Assay"
    ],
    "Submitter Information": "Diagnostic Hybrids, Inc.",
    "510(k) Number": "K092300",
    "Predicate Device Reference 510(k) Number(s)": [
        "K061101"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "GNW"
    ],
    "Summary Letter Date": "August 28, 2009",
    "Summary Letter Received Date": "July 29, 2009",
    "Submission Date": "July 23, 2009",
    "Regulation Number(s)": [
        "21 CFR 866.3330"
    ],
    "Regulation Name(s)": [
        "Influenza virus serological reagents"
    ],
    "Analyte Class(es)": [
        "virology",
        "microbiology"
    ],
    "Analyte(s)": [
        "Influenza A",
        "Influenza B",
        "Respiratory Syncytial Virus (RSV)",
        "Adenovirus",
        "Parainfluenza 1",
        "Parainfluenza 2",
        "Parainfluenza 3"
    ],
    "Specimen Type(s)": [
        "Respiratory specimens",
        "Nasopharyngeal aspirates",
        "Nasopharyngeal washes",
        "Swabs (nasal, throat, nasopharyngeal)",
        "Bronchial alveolar lavages",
        "Tracheal aspirates"
    ],
    "Specimen Container(s)": [
        "Transport medium in centrifuge tube",
        "Universal Transport Medium"
    ],
    "Instrument(s)/Platform(s)": [
        "Fluorescence microscope",
        "Cell culture systems",
        "Shell vials",
        "Multi-well plates"
    ],
    "Method(s)/Technology(ies)": [
        "Direct fluorescent antibody (DFA) immunofluorescence",
        "Cell culture",
        "Immunostaining with fluoresceinated monoclonal antibodies"
    ],
    "Methodologies": [
        "Immunofluorescence microscopy",
        "Direct antigen detection",
        "Cell culture confirmation"
    ],
    "Submission Type(s)": [
        "Kit",
        "Reagent",
        "Assay",
        "Control Slides"
    ],
    "Document Summary": "FDA 510(k) summary for D3 Ultra DFA Respiratory Virus Screening & ID Kit for qualitative detection of seven respiratory viruses in respiratory specimens by DFA and cell culture",
    "Indications for Use Summary": "Qualitative detection and identification of Influenza A, Influenza B, RSV, Adenovirus, Parainfluenza 1, 2, and 3 viruses in respiratory specimens via direct detection or cell culture using immunofluorescence with monoclonal antibodies; negative results should be confirmed by cell culture and not used as sole basis for diagnosis.",
    "fda_folder": "Microbiology"
}